UK markets closed

Opthea Limited (OPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.5400-0.2900 (-7.57%)
As of 10:47AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.8300
Open3.7500
Bid0.0000 x 0
Ask0.0000 x 0
Day's range3.5300 - 3.7500
52-week range1.6000 - 4.4200
Volume1,434
Avg. volume26,209
Market cap293.292M
Beta (5Y monthly)0.73
PE ratio (TTM)N/A
EPS (TTM)-2.4100
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est12.78
  • Simply Wall St.

    Owning 39% shares,institutional owners seem interested in Opthea Limited (ASX:OPT),

    Key Insights Institutions' substantial holdings in Opthea implies that they have significant influence over the...

  • GlobeNewswire

    Opthea Appoints John Han, PharmD, as VP Medical Affairs

    Brings extensive experience in retinal and ophthalmology diseasesMELBOURNE, Australia and PRINCETON, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the appointment of John Han, PharmD, to the role of Vice President, Medical Affairs, effective A

  • GlobeNewswire

    Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference

    MELBOURNE, Australia and PRINCETON, N.J., April 04, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference and participate in one-on-one investor meetings on April 11, 2024. 23rd Ann